Illumina CEO Jay T. Flatley Sells 5,000 Shares (ILMN)
Illumina (NASDAQ:ILMN) CEO Jay T. Flatley sold 5,000 shares of Illumina stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $152.23, for a total transaction of $761,150.00. Following the completion of the sale, the chief executive officer now directly owns 398,105 shares in the company, valued at approximately $60,603,524. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
ILMN has been the subject of a number of recent research reports. Analysts at Leerink Swann set a $160.00 price target on shares of Illumina in a research note to investors on Wednesday, January 29th. Separately, analysts at Mizuho raised their price target on shares of Illumina from $150.00 to $175.00 in a research note to investors on Wednesday, January 29th. They now have a “buy” rating on the stock. Finally, analysts at ISI Group raised their price target on shares of Illumina from $134.50 to $147.00 in a research note to investors on Wednesday, January 29th. They now have a “neutral” rating on the stock. Six research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $117.24.
Shares of Illumina (NASDAQ:ILMN) traded up 3.08% during mid-day trading on Monday, hitting $161.74. 2,476,013 shares of the company’s stock traded hands. Illumina has a 52-week low of $48.00 and a 52-week high of $157.24. The stock’s 50-day moving average is $128.1 and its 200-day moving average is $96.44. The company has a market cap of $20.494 billion and a P/E ratio of 174.33.
Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, January 28th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.01. The company had revenue of $387.00 million for the quarter, compared to the consensus estimate of $382.06 million. During the same quarter in the previous year, the company posted $0.42 earnings per share. The company’s revenue for the quarter was up 25.1% on a year-over-year basis. Analysts expect that Illumina will post $2.06 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.